Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Many patients report feeling better on a gluten-free diet, but gluten may not always be the culprit. Nonceliac wheat sensitivity (NCWS) can be triggered by fructans, amylase-trypsin inhibitors, or even the nocebo effect — not just gluten. Clinicians should rule out celiac disease and wheat allergy before recommending dietary changes, and avoid unnecessary long-term elimination diets.
About 10% of the global population reports gluten or wheat sensitivity, yet double-blind challenge tests confirm true gluten reactivity in fewer than 30% of those cases. The condition — now more accurately called nonceliac wheat sensitivity (NCWS) — may be triggered by multiple wheat components, including fructans (a type of fermentable carbohydrate) and amylase-trypsin inhibitors (ATIs), which can activate innate immune responses. The nocebo effect also plays a meaningful role: in blinded studies, the mere expectation of consuming gluten can drive more symptoms than actual gluten exposure.
For primary care physicians, the diagnostic path matters as much as the destination. NCWS is an exclusion diagnosis — celiac disease and wheat allergy must be ruled out first, while the patient is still on a normal diet. Symptoms typically include IBS-like complaints (bloating, abdominal pain, altered bowel habits) plus extraintestinal clues like fatigue, brain fog, and joint pain, appearing within hours to two days of wheat consumption.
Key Takeaways:
Why it matters: With gluten-free diets growing in popularity, clinicians risk over-diagnosing NCWS and under-investigating serious conditions. A structured, stepwise diagnostic approach protects patients from unnecessary dietary restrictions and ensures conditions like celiac disease or wheat-dependent exercise-induced anaphylaxis aren't missed.
